Shanghai Fosun Pharmaceutical Group Co Ltd

Price Chart

Risk-Adjusted Performance

Also Listed On

Shanghai Fosun Pharmaceutical Group Co Ltd (600196) Price Performance

Shanghai Fosun Pharmaceutical Group Co Ltd (600196) trades on SHG in CNY. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at CNY26.15, down 2.06% from the previous close.

Over the past year, 600196 has traded between a low of CNY23.40 and a high of CNY32.15. The stock has gained 7.2% over this period. It is currently 18.7% below its 52-week high.

Shanghai Fosun Pharmaceutical Group Co Ltd has a market capitalization of $69.83B, with a price-to-earnings ratio of 20.59 and a dividend yield of 1.46%.

About Shanghai Fosun Pharmaceutical Group Co Ltd

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical business in Mainland China and internationally. It operates through five segments: Pharmaceuticals, Medical Devices and Medical Diagnosis, Medical Services, Medical Distribution and Retail, and Others. The company is involved in the pharmaceutical manufacturing in the therapeutic areas of solid oncology, including tumors and hematologic malignancies, as well as immune-inflammatory disorders, metabolism and digestive systems, anti-infection, central nervous system, cardiovascular system, and APIs and intermediates. It also offers mRNA vaccines; medical aesthetic devices, such as medical aesthetic capital equipment, aesthetic dentistry, injectables, and personal care business units; mechanical ventilation devices under the Breas brand; and mobile pre-hospital care; professional in-hospital surgery and covers medical devices; and high-end surgical robots and medical consumables. In addition, the company provides diagnostics solutions comprising biochemical diagnostics, immune diagnostics, molecular diagnostics, microbiological diagnostics, pathological diagnostics, and chronic care management; and healthcare services, specialized medical treatment, online and offline medical services, and insurance services. Further, it engages in the operation of hospitals; and distribution and retail of healthcare products. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.